Apogee Therapeutics Inc. (APGE)
NASDAQ: APGE
· Real-Time Price · USD
37.36
-0.76 (-1.99%)
At close: Aug 15, 2025, 3:59 PM
36.48
-2.36%
After-hours: Aug 15, 2025, 07:58 PM EDT
Apogee Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Net Income | -66.1M | -55.34M | -67.22M | -49.02M | -33.82M | -32.09M | -31.73M | -20.84M | -18.89M | -12.53M | -14.01M | -19.66M | -1.82K | -4.3K |
Depreciation & Amortization | 399K | 207K | 76K | 48K | 36K | 29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 11.34M | 11.13M | 7.61M | 5.84M | 5.7M | 4.19M | 2.21M | 1.5M | 1.11M | 1.27M | 2.14M | n/a | n/a | n/a |
Other Working Capital | -10.07M | -4.32M | -4.81M | 7.04M | 317K | -3.47M | 1.49M | 9.45M | -6.66M | 217K | 1.73M | 3.23M | 1.59K | 1.72K |
Other Non-Cash Items | -839K | -1.52M | -2.23M | 836K | -2.76M | -2.44M | -2.75M | -232K | 9.86K | 477.00 | 563K | 9.15M | 221.00 | 2.58K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -6.84M | -2.95M | -5.96M | -229K | 1.54M | -1.31M | 2.52M | -313K | 3.2M | 694K | 2.11M | 3.27M | 1.59K | 1.72K |
Operating Cash Flow | -62.03M | -48.48M | -67.71M | -42.52M | -29.3M | -31.64M | -29.75M | -19.88M | -14.57M | -10.56M | -9.19M | -7.24M | n/a | n/a |
Capital Expenditures | -768K | -4.32M | 1K | -751K | -51K | -351K | -167K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -47.38M | -98.2M | -60.58M | -236.01M | -226.97M | -125.89M | -69.53M | -234.22M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 126.27M | 115.5M | 106.95M | 90.38M | 78.31M | 74.5M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -234.22M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 78.13M | 12.98M | 46.37M | -146.38M | -148.71M | -51.74M | -273.91M | -234.22M | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 24K | n/a | 1.69M | -1.69M | n/a | 173.8K | 4.85M | -26 | 5K |
Financial Cash Flow | 1.18M | 622K | 44.36M | 383K | -150K | 450.52M | -213K | 317.3M | -1.69M | n/a | 173.8K | 4.85M | -26 | 5K |
Net Cash Flow | 17.28M | -34.87M | 23.01M | -188.52M | -178.16M | 367.14M | -69.95M | 63.2M | -16.26M | -10.56M | 149.31M | -2.39K | -26 | 5K |
Free Cash Flow | -62.8M | -52.79M | -67.71M | -43.27M | -29.35M | -31.99M | -29.92M | -19.88M | -14.57M | -10.56M | -9.19M | -7.24M | n/a | n/a |